Automated Cell Culture Market Size, Share & Industry Analysis, By Type (Model System and Integrated System), By Application (Academic and Research Institutes, and Biopharma Companies), Regional Insights and Forecast From 2025 To 2033

• 

  Request a Free sample to learn more about this report

AUTOMATED CELL CULTURE MARKET OVERVIEW

The global automated cell culture market size was valued at USD 0.24 billion in 2024 and market is projected to touch USD 0.49 billion by 2033, at a CAGR of 8.2% during the forecast period from 2025 To 2033.

To get an understanding of the product, an automated cell culture system is an apparatus that as a reflex action conducts out the phases implicated in increasing and sustaining a cell culture. Furthermore, the product can be vitally advantageous in segregated and several laboratories that function productively with cell culture in mainly biology, cell indicating, protein expression, or drug detection, an automated cell culture procedure assists to cultivate cell cultures whereas redeeming and minimizing labor time periods and plummeting the amounts of errors occurring. Moreover, the automated cell culture can be adopted and very much proficient of diluting experiments, nurturing numerous cultures in liquefied solutions with persistent churning, coating cultures, or employing the specified cultures in shafts.

On the other hand, the automated cell culture market is diversified into two types such as a unique model system and an integrated system. Firstly, a model system that is basically a study of basic cell biology, replicate disease mechanisms, or investigate the toxicity of novel drug compounds. Moreover, this type of system is capable of initially connecting to create a never ending source of chemical and biological substances. Furthermore, a model system is highly consumed in healthcare markets such as cancer research, basic medical research and mainly in drug detection sectors as it offers a stage to examine the biology, biochemistry, physiology and metabolism of different kind of cells and other ailing cells. Whereas, the integrated system looks forward to alter the characteristics of health care from responsive to pre-emptive, from divided to synchronized, and from stationary to vigorous. Furthermore, integrated system and care is the most vital way to enhance and improve upon the quality of the outcomes for the most recurrent and expensive care, for the ageing and other several patients with severe chronic ailments.

COVID-19 IMPACT

Required Usage of Cell Culture and Line for COVID-19 Vaccine

The global COVID-19 pandemic has been unprecedented and staggering, with the Automated Cell Culture Market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden rise in CAGR is attributable to the market's growth and demand returning to pre-pandemic levels once the pandemic is over.

The COVID-19 had several unwanted implications upon the automated cell cultures market. This was accounted for, as numerous researches were focused to produce a COVID-19 cure and vaccination and the pharmaceutical companies necessitated a high demand and consumption for cell lines. Furthermore, researchers and manufacturers had been aimed to develop automated cell culture based vaccinations due to augmented global demand for safety protocols for new treatments to constraint and get rid of the COVID-19’s relentless growth on a global scale. Hence, the requirement for apparatuses grew globally, as COVID-19 pandemic was at its peak.

LATEST TRENDS

Surging Demand for 3D Cell Cultures Raises Level of Overall Demand

The current trend the market experiences, is the increasing demand for 3D cell culture.  This is accounted for, as several prominent key organizations are strategizing on developing newer, productive and efficient products. Furthermore, using 3D cell cultures can develop vital bioreactors and software platforms, and generating wider opportunities for the market. Hence, stimulating a rise of higher demand from consumers in the academic and research institutes and biopharma companies.

Request a Free sample to learn more about this report

AUTOMATED CELL CULTURE MARKET SEGMENTATION

By Type

Based on type; Model system and integrated system

Model system is the leading type in this segment

By Application

Based on application; Academic and research institutes and biopharma companies

Biopharma companies is the leading application in this segment

DRIVING FACTORS

Surged Vaccine Demands Needs Cell Cultures System and Augments Market Growth

The usage of cell cultures in vaccine was adopted during the COVID-19 pandemic, and has yet continued as it is very beneficial and applicable to this particular segment. Furthermore, the cell cultures are consumed as a substitute to egg based methods in vaccine development. Moreover, the cell cultures properties help in combating numerous chronic diseases and other ailments such as polio, chicken pox and rubella. Hence, more consumers within the market and other diversified markets recognize the consuming benefits, and positively stimulate demand through increased product demand. This leads towards the automated cell culture market growth.

RESTRAINING FACTORS

High Expenditure Costs Included with the Product Hinders Market Growth

One of the rising restraints of the product the market is likely to experience, is the expensive costs coming along with and for the usage of the product. Furthermore, the initial cost to purchase the product is significantly costlier than other apparatuses and its components prices can exceed the initial costs. These constraints, can force consumers to switch to competitors or alternatives and, which is expected to hamper the market growth over the projected period.

Innovation and Improvements in Automated Cell CultureBoosts Market Growth

The surges in demand for the product within the market are recorded due to, the product being put through uncountable amount of research and development procedures. Furthermore, this advancements offers the product to be more efficient in cancer research, virology and other extensive experiments and widens its application base. As the cell cultures are more applicable for diverse experiments and tests, producers adopt their usage as to boost their own consumer base and dimensions within the market. Hence, which also augments the level of demand and supply while also boosting the automated cell culture market share.

• Request a Free sample to learn more about this report

•  

AUTOMATED CELL CULTURE MARKET REGIONAL INSIGHTS

North American Region Claims onto Leading Market Position

North American region stands tall over others in the industry, due to having high investments diverted towards the healthcare and pharmaceutical markets. Furthermore, these funds develop laboratories so they conduct extensive researches and carry out experiments, in return boosting the demand for product within the market and the region itself. 

KEY INDUSTRY PLAYERS

Key Players Aim to Grow Awareness Rates

The key market players look to increase the level of awareness of the cell cultures, as it is currently only limited towards the healthcare sectors. Furthermore, as awareness spreads and demand grows, it would benefit the key industry players to grow their customer base, revenue, market share and position in the long run. Additionally, the key players also advertise the products properties and applications to raise awareness within the market and other diverse markets.

List of Top Automated Cell Culture Companies

• Danaher (U.S.)
• Sartorius (Germany)
• GE (U.S.)
• Tecan (Switzerland)
• Agilent (India)
• SHIBUYA (Japan)
• Hamilton Company (U.S.)
• Merck KgaA (Germany)
• Lonza (Switzerland)
• Kawasaki (Japan)
• Biospherix (U.S.)
• Cell Culture Company (U.S.)
• Aglaris (U.K.)
• Icomes Lab (Japan)

INDUSTRY DEVELOPMENT

August 2021:  Advanced Instruments, a prominent producer of analytical apparatus and services for bioprocessing, launched an ultimate contract to obtain solentim, a reliable and recognized global leader of solutions for the seclusion of high-value single-cell replicas in cell line development (CLD).

July 2021:  BD has initiated bdbiosciences.com, a renewed digital marketplace for flow cytometry. The new website delivers an improved online buying involvement for flow cytometry consumers and their purchasing members.

REPORT COVERAGE

This report highlights types in the automated cell culture market and the markets latest trends along with driving and restraining factors. Additionally, this report is inclusive of the key industry players and their strategies, also mentions reasons how the leading region claims its entitlement.